Viewing Study NCT03173092


Ignite Creation Date: 2025-12-24 @ 3:57 PM
Ignite Modification Date: 2026-02-28 @ 9:25 PM
Study NCT ID: NCT03173092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-28
First Post: 2017-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module